BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)
$60
About BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Details
Daily high
$7.83
Daily low
$7.38
Price at open
$7.81
52 Week High
$11.22
52 Week Low
$6.23
Market cap
1.9B
Dividend yield
-
Volume
1.8M
Avg. volume
5.8M
P/E ratio
-5.37
BioCryst Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$7.83
Daily low
$7.38
Price at open
$7.81
52 Week High
$11.22
52 Week Low
$6.23
Market cap
1.9B
Dividend yield
-
Volume
1.8M
Avg. volume
5.8M
P/E ratio
-5.37